Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Prof Dr. Tao Sun | Nucleic Acid Drug | Best Researcher Award

Nankai University | China

Author Profile

Scopus

Orcid ID

šŸ“š Prof. Tao Sun: Innovator in Oncology and Drug Development

šŸŽ“Position:

  • Professor and Doctoral Supervisor, College of Pharmacy, Nankai University, China šŸŽ“

šŸŒŸTitles and Awards:

  • National Youth Talent šŸŒŸ
  • Winner of the Tianjin Distinguished Youth Scholar šŸ†

šŸ”¬Research Focus:

  • Molecular mechanisms of malignant tumors šŸ§¬
  • Drug development šŸ’Š
  • Pharmacology šŸ”¬

šŸ“„Publications:

  • Over 40 papers in prestigious journals, including Advanced Materials, Science Translational Medicine, Hepatology, and Cancer Research, as the first or corresponding author. šŸ“„

šŸ“œPatents and Approvals:

  • More than 20 authorized patents šŸ“œ
  • 3 new drug clinical approvals āœ…

šŸ§ŖResearch Leadership:

  • Principal investigator of 8 major scientific research projects, including Major National Science and Technology Projects and general projects of the National Natural Science Foundation of China. šŸ§Ŗ

šŸ„‡Achievements in Education:

  • Instructed students to win the Gold Award in the China International College Students’ “Internet+” Innovation and Entrepreneurship Competition šŸ„‡
  • Recipient of the “Top Ten Award of Scholarly Mentor and Beneficial Friend” at Nankai University šŸŽ–
  • Second Prize winner of the Nankai University Teaching Achievement Award šŸ„ˆ

šŸ’ŠSummary:

  • Prof. Tao Sun is a distinguished scholar and innovator at Nankai University, renowned for his contributions to oncology, drug development, and pharmacology. His prolific research, numerous patents, and leadership in significant scientific projects underscore his impact in the field. As an educator, he has been instrumental in guiding students to achieve excellence, earning recognition for his mentorship and teaching achievements. šŸŒŸšŸ”¬šŸ’Š

 

šŸ“ŠšŸ”¬Notable Publication:

 

Interaction between laminin-5Ī³2 and integrin Ī²1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1

  • Authors: Cai, S., Bi, Z., Bai, Y., … Liu, H., Yang, C.
    Journal: Frontiers in Oncology
  • Year: 2020

 

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

  • Authors: Meng, J., Han, J., Wang, X., … Liu, H., Sun, T.
    Journal: Pharmacological Research
  • Year: 2023

 

Correction: Interaction between laminin-5Ī³2 and integrin Ī²1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins

  • Authors: Zhou, B., Zong, S., Zhong, W., … Sun, T., Liu, Y.
    Journal: Oncogene
  • Year: 2020

 

YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma

  • Authors: Han, J., Meng, J., Chen, S., … Sun, T., Yang, C.
    Journal: Cancer Research
  • Year: 2019

Aya H. Soliman – Tumor Immunology – Best Researcher Award

Ms.Aya H. Soliman - Tumor Immunology - Best Researcher Award

German University in Cairo - Egypt

AUTHOR PROFILE

Scopus

OrcidĀ 

EARLY ACADEMIC PURSUITS:

Aya H. Soliman's academic journey commenced with a fervent pursuit of knowledge. Her early years were marked by a dedication to learning, demonstrating an insatiable curiosity and a penchant for academic excellence. Whether it be notable achievements, academic milestones, or early influences, this period laid the foundation for her future endeavors.

PROFESSIONAL ENDEAVORS:

Embarking on a path of professional growth, Soliman transitioned seamlessly from academia to the professional realm. Her career trajectory reflects a commitment to applying theoretical knowledge to real-world challenges. A closer examination of her professional undertakings unveils a strategic and purposeful approach to making significant contributions in her chosen field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Soliman's contributions to her field are nothing short of groundbreaking. Her research focus is characterized by a meticulous exploration of pertinent issues, coupled with innovative methodologies. By delving into specific themes, she has enriched the academic landscape with fresh perspectives and novel insights, leaving an indelible mark on her area of expertise.

IMPACT AND INFLUENCE:

The impact of Soliman's work extends far beyond the confines of academia. Her research and professional activities have influenced not only fellow scholars but also practitioners in the field. By contributing to the advancement of knowledge, she has played a pivotal role in shaping industry practices and policies, showcasing a far-reaching influence.

ACADEMIC CITES:

A quantitative measure of Soliman's academic influence lies in the citation of her work. The number of times her research has been referenced underscores its significance within scholarly discourse. Her contributions have become integral to the academic canon, with citations serving as a testament to the enduring relevance of her ideas.

FUTURE CONTRIBUTIONS:

Looking ahead, Soliman's future contributions hold promise for continued innovation and advancement. Anticipating the evolving landscape of her field, she remains poised to address emerging challenges and contribute novel solutions. The trajectory of her future contributions is eagerly awaited, promising to shape the direction of academic and professional discourse.

Notable Publications

Phytochemical-derived tumor-associated macrophage remodeling strategy usingĀ Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis. 2023